The ELISA allergy profile is a blood test using an enzyme-linked immunosorbent assay to measure allergen-specific antibodies (typically IgE) against multiple allergens (foods, pollens, dust mites, animal dander). Allergens bind in wells and antibody binding is detected and quantified by an enzyme reaction. Results show sensitization patterns to guide diagnosis and management but must be interpreted with clinical history because false positives/negatives occur.

An allergy profile typically includes skin prick testing and specific IgE blood tests (e.g., ImmunoCAP) to identify immediate-type allergies. Patch tests detect delayed contact allergies. Component-resolved diagnostics can pinpoint specific allergen proteins. In some cases, supervised oral food or drug challenge is used to confirm clinical reactivity. Evaluation also considers medical history and symptom patterns for accurate interpretation.

The ELISA for IgE is a blood test that quantitatively measures total or allergen-specific IgE antibodies. Patient serum is added to antigen- or anti-IgE-coated wells; bound IgE is detected with an enzyme-linked secondary antibody, producing a color change proportional to antibody level. Results help identify allergic sensitization and guide management but must be interpreted with clinical history due to possible false results.

ELISA (enzyme-linked immunosorbent assay) is used to detect and quantify specific antigens or antibodies in blood or other fluids to confirm infection, immune response, or presence of biomarkers. Common uses include confirming viral infections (HIV, hepatitis B and C), certain bacterial or parasitic infections, autoimmune antibodies, pregnancy hormones, and monitoring vaccine- or exposure-related antibody levels.

A positive ELISA (enzyme-linked immunosorbent assay) means the test detected the specific antibody or antigen above the assay’s cutoff. For antibody tests it suggests past exposure, vaccination response, or possible recent infection; for antigen tests it points to active infection. Results can yield false positives or negatives, so confirmatory testing and clinical correlation with symptoms and history are recommended.

If an allergy test is positive, it means your immune system reacts to that substance but must be correlated with symptoms. Your clinician will review results, advise avoidance and symptom control (antihistamines, nasal steroids), and may prescribe an epinephrine auto‑injector if anaphylaxis risk exists. Options include allergen immunotherapy (shots or sublingual) and further testing or specialist referral to confirm diagnosis and guide treatment.